Teachers Grow Mustaches for Cancer

A teacher who battled Hodgkin's Lymphoma raised awareness by growing a mustache with his colleagues:

"Andy Fleming is all too familiar with cancer.

Not only was he diagnosed with Hodgkin's disease, a cancer of the lymphatic system, but his mother suffered from breast and pancreatic cancer and his father has prostate cancer. But beyond his family, he discovered two things when he discussed his ailment.

He found many people believe women have a significantly higher cancer rate than men, even though the National Cancer Institute estimates that half the 1.5 million people who will be diagnosed with cancer this year are men. He also noticed that too often men don't like talking about their condition after being diagnosed.

Wanting to bring awareness about male cancer in an innovative way, Fleming convinced his school district and colleagues to plug into an international program.

They agreed to grow mustaches."

Read More: http://www.democratandchronicle.com/article/20101201/NEWS01/12010342/100...

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap